Effects of 25-OH-D3 Vitamin Substitution in Congestive Heart Failure. Controlled, Randomized, Double Blind Trial

Trial Profile

Effects of 25-OH-D3 Vitamin Substitution in Congestive Heart Failure. Controlled, Randomized, Double Blind Trial

Suspended
Phase of Trial: Phase III

Latest Information Update: 18 Feb 2014

At a glance

  • Drugs Colecalciferol (Primary)
  • Indications Chronic heart failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Mar 2013 Planned End Date changed from 1 Sep 2012 to 1 Sep 2017 as reported by ClinicalTrials.gov.
    • 29 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top